Clincosm LogoSign in Get a demo

metastatic malignant neoplasm

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Tumor Trial in United States (NPX267)

Not yet recruiting
  • Metastatic Malignant Neoplasm
  • Baltimore, Maryland
  • +5 more
Jul 21, 2023

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +2 more
  • Laboratory Biomarker Analysis
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Advanced Malignant Tumor, Delirium, Locally Advanced Malignant Tumor Trial in Houston (Chlorpromazine, Haloperidol,

Active, not recruiting
Has Results
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Financial Distress in Advanced Cancer Patients

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Medical Chart Review
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance

Active, not recruiting
  • Metastatic Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Bone
  • Fludeoxyglucose F-18
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Skin Squamous Cell Carcinoma, Appendix Adenocarcinoma, Rare Lesion Trial in Houston (Atezolizumab, Cobimetinib)

Active, not recruiting
  • Skin Squamous Cell Carcinoma
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Advanced Malignant Tumor, Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Caregiver Burden, Quality of Life, and Symptom Distress at

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Mar 2, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting
  • Human Papillomavirus-16 Positive
  • +20 more
  • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2022

Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Houston (Cognitive Assessment, Quality-of-Life

Active, not recruiting
  • Metastatic Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Brain
  • Cognitive Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2021

Locally Advanced Malignant Tumor, Metastatic Malignant Tumor Trial (Quality-of-Life Assessment, Questionnaire Administration,

Withdrawn
  • Locally Advanced Malignant Neoplasm
  • Metastatic Malignant Neoplasm
  • Quality-of-Life Assessment
  • +2 more
  • (no location specified)
May 12, 2021

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Anakinra
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Cerebral Vein Thrombosis, Deep Vein Thrombosis, Gonadal Thrombosis Trial in United States (Apixaban, Dalteparin, Questionnaire

Completed
Has Results
  • Cerebral Vein Thrombosis
  • +11 more
  • Scottsdale, Arizona
  • +17 more
Jul 31, 2020

Delirium, Locally Advanced Malignant Tumor, Metastatic Malignant Tumor Trial in Houston, Richmond, Barretos (Haloperidol,

Recruiting
  • Delirium
  • +3 more
  • Houston, Texas
  • +2 more
Jul 21, 2020

HLA-A2 Positive Cells Present, Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Bronx (biological,

Unknown status
  • HLA-A2 Positive Cells Present
  • +2 more
  • Aldesleukin
  • +5 more
  • Bronx, New York
    Albert Einstein College of Medicine
Mar 5, 2020

Metastatic Malignant Tumor, Solid Tumor, Unresectable Malignant Tumor Trial in Chicago (Ilorasertib, Laboratory Biomarker

Completed
  • Metastatic Malignant Neoplasm
  • +2 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 18, 2019

Metastatic Malignant Tumor Trial in Herlev (Plasmid AMEP)

Terminated
  • Metastatic Malignant Neoplasm
  • Plasmid AMEP
  • Herlev, Denmark
    Depart. of Oncology, Copenhagen Universtiy Hospital Herlev
Jun 19, 2014